Skip to Content

Join the 'Phosphocol P-32' group to help and get support from people like you.

Phosphocol P-32 News

FDA Medwatch Alert: Phosphocol P 32 (Chromic Phosphate P 32 Suspension)

Posted 18 Sep 2008 by

[Posted 09/18/2008] Covidien and Mallinckrodt Inc. informed healthcare professionals of important new safety information in prescribing Phosphocol P 32. Phosphocol P 32 is approved for the intracavitary instillation for the treatment of peritoneal or pleural effusions caused by metastatic disease. Phosphocol P 32 may increase the risk for leukemia in certain situations. Two children (ages 9 and 14) with hemophilia developed acute lymphocytic leukemia approximately 10 months after intra-articular injections of Phosphocol P 32 (0.6 and 1.5 mCi total dose). This drug is not indicated in the intra-articular treatment of hemarthroses. Additionally, post marketing experience identified radiation injury (necrosis and fibrosis) to the small bowel, cecum, and bladder following administration of P 32 into the peritoneal cavity. Healthcare professionals should refer to the product's revised ... Read more

Related support groups: Phosphocol P-32

Ask a Question

Further Information

Phosphocol P-32 Patient Information at